We are live on
!
Find out more
UOC
UBS O'Connor Portfolio holdings
AUM
$3.38B
1-Year Est. Return
63.08%
This Fund
S&P 500
This Quarter
Est. Return
+16.95%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$1.52B
AUM Growth
-$7.28B
(-83%)
Cap. Flow
-$6.76B
Cap. Flow
% of AUM
-444.29%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
929
New
–
Increased
6
Reduced
3
Closed
920
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$184M |
| 2 |
First Horizon
FHN
|
+$107M |
| 3 |
SGFY
Signify Health, Inc.
SGFY
|
+$54.9M |
| 4 |
VMW
VMware, Inc
VMW
|
+$34.9M |
| 5 |
ONEM
1Life Healthcare
ONEM
|
+$29.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$572M |
| 2 |
ZEN
ZENDESK INC
ZEN
|
+$456M |
| 3 |
Rogers Corp
ROG
|
+$432M |
| 4 |
AVLR
Avalara, Inc.
AVLR
|
+$373M |
| 5 |
SWCH
Switch, Inc. Class A Common Stock
SWCH
|
+$271M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 45.54% |
| 2 | Healthcare | 36.97% |
| 3 | Financials | 14.43% |
| 4 | Communication Services | 3.06% |
| 5 | Energy | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MTAL
201
DELISTED
Metals Acquisition
MTAL
| – | – |
-229,785
| Closed | -$2.25M |
|
202
Meritage Homes
MTH
$4.71B
| – | – |
-184,932
| Closed | -$6.5M |
|
203
MasTec
MTZ
$20.8B
| – | – |
-25,228
| Closed | -$1.6M |
|
204
Murphy Oil
MUR
$4.74B
| – | – |
-44,836
| Closed | -$1.58M |
|
205
PUT
Navient
NAVI
$892M
| – | – |
-107,800
| Closed | -$361K |
|
206
Neurocrine Biosciences
NBIX
$16.2B
| – | – |
-17,003
| Closed | -$1.81M |
|
207
Norwegian Cruise Line
NCLH
$8.89B
| – | – |
-247,861
| Closed | -$2.82M |
|
|
208
PUT
Norwegian Cruise Line
NCLH
$8.89B
| – | – |
-69,200
| Closed | -$904K |
|
209
NextEra Energy
NEE
$176B
| – | – |
-53,062
| Closed | -$4.16M |
|
210
PUT
NGL Energy Partners
NGL
$2.17B
| – | – |
-81,300
| Closed | -$98K |
|
211
National Health Investors
NHI
$3.65B
| – | – |
-124,319
| Closed | -$7.03M |
|
212
NIO
NIO
$11.5B
| – | – |
-182,673
| Closed | -$2.88M |
|
213
NNN REIT
NNN
$9.02B
| – | – |
-12,200
| Closed | -$486K |
|
214
NET Power
NPWR
$133M
| – | – |
-477,246
| Closed | -$4.7M |
|
215
NRG Energy
NRG
$25B
| – | – |
-26,623
| Closed | -$1.02M |
|
|
NSA
216
DELISTED
National Storage Affiliates Trust
NSA
| – | – |
-323,820
| Closed | -$13.5M |
|
217
Nutrien
NTR
$31.9B
| – | – |
-110,193
| Closed | -$9.19M |
|
|
NVNO
218
enVVeno Medical
NVNO
$6.78M
| – | – |
-4,278
| Closed | -$940K |
|
219
NVR
NVR
$16.8B
| – | – |
-195
| Closed | -$777K |
|
220
NXP Semiconductors
NXPI
$58.4B
| – | – |
-22,958
| Closed | -$3.39M |
|
221
Realty Income
O
$59B
| – | – |
-34,718
| Closed | -$2.02M |
|
222
OmniAb
OABI
$325M
| – | – |
-477,246
| Closed | -$4.87M |
|
223
Ocular Therapeutix
OCUL
$1.92B
| – | – |
-223,066
| Closed | -$926K |
|
224
Old Dominion Freight Line
ODFL
$43.8B
| – | – |
-64,484
| Closed | -$8.02M |
|
225
OGE Energy
OGE
$9.67B
| – | – |
-27,587
| Closed | -$1.01M |
|
Similar funds
FNBT
SAG
ACI
TCOV
RC
A
CGL
CB
UBS O'Connor's Q4 2022 Portfolio in Review
As of Q4 2022, UBS O'Connor held 929 positions worth $1.52B, down 83% from $8.8B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
UBS O'Connor withdrew a net $6.76B in Q4 2022, closing 920 positions and reducing 3 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $572M position sold in full.
By sector, the portfolio is most concentrated in Technology at 46% of assets, up from 28% a quarter earlier, followed by Healthcare and Financials.
Against the trend, UBS O'Connor added an estimated $184M to Horizon Therapeutics Public Limited Company Ordinary Shares.
- UBS O'Connor added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2022, an estimated $184M increase.
- UBS O'Connor's biggest Q4 2022 reduction was Activision Blizzard, cutting an estimated $45.3M.
- UBS O'Connor fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $572M.
- UBS O'Connor's ten largest holdings make up 100% of its $1.52B portfolio in Q4 2022.
- UBS O'Connor opened 0 new positions and closed 920 in Q4 2022.
- UBS O'Connor's portfolio value fell 83% quarter-over-quarter to $1.52B.
Based on UBS O'Connor's 13F filing for Q4 2022, filed 14 Feb 2023.